Did not become law. It stopped in the House of Representatives's Finance, Revenue and Bonding Committee on March 27, 2018. The 2018 session has ended.
2018 Regular Session
House Bill 5280
AN ACT CONCERNING A BIOSCIENCE AND BIOTECHNOLOGY INVESTMENT TAX CREDIT.
What it does
The synopsis the General Assembly published with the bill.
To establish a tax credit for certain investments in bioscience and biotechnology businesses in the state that qualify for the "incremental" research and experimental expenditures tax credit under section 12-217j of the general statutes.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
February 28 to March 27, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action7 actions on 6 days
In the House of RepresentativesFeb 28 to Mar 27 · stopped27 days
Commerce CommitteeFeb 28 to Mar 2222 days
Finance, Revenue and Bonding CommitteeMar 22 to Mar 27 · stopped5 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Feb 28 – Mar 22
- Feb 28Introduced and sent to Commerce Committee
- Mar 2Heard in Commerce Committee
- Mar 22Commerce Committee recommended it and sent it to Finance, Revenue and Bonding Committee
All 7 actions, as published
- Feb 28REF. TO JOINT COMM. ONBoth houses
- Mar 2PUBLIC HEARINGBoth houses
- Mar 22Joint Favorable Change of ReferenceBoth houses
- Mar 23FILED WITH LCOBoth houses
- Mar 26RPTD. OUT OF LCOBoth houses
- Mar 26FAV. CHG. OF REF. HOUSE TO COMM. ONHouse of Representatives
- Mar 27FAV. CHG. OF REF., SEN. TO COMM. ONSenate